Literature DB >> 15576469

Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride].

Marcella Rocchetti1, Alessandra Besana, Gaspare Mostacciuolo, Rosella Micheletti, Patrizia Ferrari, Sandor Sarkozi, Csaba Szegedi, Istvan Jona, Antonio Zaza.   

Abstract

OBJECTIVE: To gain some insight on the lesser arrhythmogenic properties of PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride] compared with digoxin, we compared modulation of intracellular Ca2+ dynamics by the two agents.
METHODS: SERCA (sarcoplasmic reticulum Ca2+-ATPase) activity and Ca2+ leak rate were measured in sarcoplasmic reticulum (SR) vesicles from guinea pig ventricles. Membrane current, intracellular Ca2+, and twitch amplitude were evaluated in guinea pig ventricular myocytes with or without blockade of the Na+/Ca2+ exchanger.
RESULTS: In SR vesicles, PST2744 (30-300 nM), but not digoxin, increased SERCA activity; digoxin only (> or =0.1 nM) increased SR Ca2+ leak. In myocytes with blocked Na+/Ca2+ exchanger, Ca2+ reloading of caffeine-depleted SR was enhanced by PST2744 and slightly inhibited by digoxin. In myocytes with functioning Na+/Ca2+ exchanger, both agents increased diastolic Ca2+, SR Ca2+ content, the gain of Ca2+-induced Ca2+ release, the rate of cytosolic Ca2+ decay, twitch amplitude, and relaxation rate. Consistent with the observations in SR vesicles, the effects on SR Ca2+ content and Ca2+ decay rate were significantly larger for PST2744 than for digoxin.
CONCLUSIONS: In isolated SR vesicles, PST2744 and digoxin directly affected SR function in opposite ways; this could be reproduced in myocytes during Na+/Ca2+ exchanger blockade. Under physiological conditions (functioning Na+/Ca2+ exchanger), the two agents affected Ca2+ dynamics in the same direction, as expected by their Na+/K+ pump inhibition; however, differential SR modulation was still expressed by quantitative differences. Thus, the more favorable inotropy-to-toxicity ratio previously described for PST2744 appears to be associated with direct SERCA stimulation and/or lack of enhancement of Ca2+ leak.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15576469     DOI: 10.1124/jpet.104.077933

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?

Authors:  Umberto Campia; Savina Nodari; Mihai Gheorghiade
Journal:  Curr Heart Fail Rep       Date:  2010-09

2.  SERCA2a stimulation by istaroxime: a novel mechanism of action with translational implications.

Authors:  Christopher L H Huang
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

3.  Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.

Authors:  Mara Ferrandi; Paolo Barassi; Francesco Tadini-Buoninsegni; Gianluca Bartolommei; Isabella Molinari; Maria Grazia Tripodi; Cristina Reina; Maria Rosa Moncelli; Giuseppe Bianchi; Patrizia Ferrari
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 4.  Beta-adrenergic stimulation and myocardial function in the failing heart.

Authors:  Ali El-Armouche; Thomas Eschenhagen
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

5.  Novel strategies for the treatment of heart failure.

Authors:  Izhak Kehat
Journal:  Rambam Maimonides Med J       Date:  2012-04-30

6.  Toward an integrative computational model of the Guinea pig cardiac myocyte.

Authors:  Laura Doyle Gauthier; Joseph L Greenstein; Raimond L Winslow
Journal:  Front Physiol       Date:  2012-07-05       Impact factor: 4.566

Review 7.  SERCA2a gene therapy in heart failure: an anti-arrhythmic positive inotrope.

Authors:  Markus B Sikkel; Carl Hayward; Kenneth T MacLeod; Sian E Harding; Alexander R Lyon
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 8.  Targeting cardiomyocyte Ca2+ homeostasis in heart failure.

Authors:  Asmund T Roe; Michael Frisk; William E Louch
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 9.  Drug Interactions With the Ca2+-ATPase From Sarco(Endo)Plasmic Reticulum (SERCA).

Authors:  Francesco Tadini-Buoninsegni; Serena Smeazzetto; Roberta Gualdani; Maria Rosa Moncelli
Journal:  Front Mol Biosci       Date:  2018-04-11

10.  Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Beatrice Badone; Carlotta Ronchi; Francesco Lodola; Anika E Knaust; Arne Hansen; Thomas Eschenhagen; Antonio Zaza
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.